Predictive value of race in post-transplantation recurrence of focal segmental glomerulosclerosis in children

L Butani1, M S Polinsky, B A Kaiser

  • 1Department of Pediatrics, St Christopher's Hospital for Children, Philadelphia, PA, USA.

Insights

Focal segmental glomerulosclerosis (FSGS) recurrence post-transplant is high. African-American children had lower FSGS recurrence and better graft survival than other races, suggesting race is a factor in pediatric kidney transplant outcomes.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Renal Pathology

Background:

  • Focal segmental glomerulosclerosis (FSGS) is a primary cause of pediatric end-stage renal disease (ESRD).
  • High rates of FSGS recurrence after kidney transplantation (Tx) pose a significant challenge.
  • The impact of recipient race on FSGS recurrence and graft survival remains under-evaluated.

Purpose of the Study:

  • To investigate the association between recipient race and FSGS recurrence after renal transplantation in children.
  • To evaluate the impact of FSGS recurrence on graft survival in different racial groups.

Main Methods:

  • Retrospective review of pediatric renal transplants for FSGS at St Christopher's Hospital for Children (1971-1997).
  • Analysis of demographic data, including recipient race, age at diagnosis, and time to ESRD.
  • Comparison of FSGS recurrence rates and graft survival between African-American and other racial groups.

Main Results:

  • Twenty patients received 27 allografts for FSGS-related ESRD; 10 (37%) were African-American (AA) and 16 (59%) were Caucasian (C).
  • FSGS recurrence was observed in 30% of grafts (8/27).
  • FSGS recurrence occurred in 10% of AA recipients (1/10) versus 41% in other racial groups (7/17; P=0.19).
  • Graft survival was better in AA recipients with recurrence (1/1 maintained function) compared to other groups (3/7 lost grafts).

Conclusions:

  • Recipient race may influence the frequency and impact of FSGS recurrence post-kidney transplantation in children.
  • FSGS recurrence posed a greater threat to graft survival in non-African-American recipients.
  • Recipient race should be considered in pre-transplant counseling for pediatric FSGS patients.
Abstract